Company / Assets per Share
Vertex Pharmaceuticals Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$99.80
FY2025
5-year range
$51.69 / $99.80
FY2021-FY2025
Trend
+14.1%
vs FY2024
Sector context
#11 of 210
Health Care
What the data says
Among 210 Health Care companies, Vertex Pharmaceuticals is in the top 5% for assets per share. Improved from $88.44 to $99.80 over the past 2 years.
Based on SEC 10-K filings.
99.80 in FY2025 with a 5-year CAGR of +17.1%. Top quartile in the Health Care sector.
Improved from $88.44 to $99.80 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +11.8%
- 5-Year CAGR
- +17.1%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 210This company $99.80 Sector average $353.15
▼
-71.7% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 14.1% year-over-year.
- Ranks #11 out of 210 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $99.80 | +14.1% |
| FY2024 | $87.44 | -1.1% |
| FY2023 | $88.44 | +24.0% |
| FY2022 | $71.33 | +38.0% |
| FY2021 | $51.69 | +13.9% |
| FY2020 | $45.37 | +39.2% |
| FY2019 | $32.60 | +32.2% |
| FY2018 | $24.66 | +72.7% |
| FY2017 | $14.28 | +21.4% |
| FY2016 | $11.76 | +13.8% |
As of FY2025 · SEC 10-K · Updated Mar 17, 2026